Division of Cell & Molecular Biology, South Kensington Campus, Imperial College, London SW7 2AZ, UK.
Neuron. 2012 Jan 12;73(1):23-34. doi: 10.1016/j.neuron.2011.12.012.
Over the past two decades, research has identified extrasynaptic GABA(A) receptor populations that enable neurons to sense the low ambient GABA concentrations present in the extracellular space in order to generate a form of tonic inhibition not previously considered in studies of neuronal excitability. The importance of this tonic inhibition in regulating states of consciousness is highlighted by the fact that extrasynaptic GABA(A) receptors (GABA(A)Rs) are believed to be key targets for anesthetics, sleep-promoting drugs, neurosteroids, and alcohol. The neurosteroid sensitivity of these extrasynaptic GABA(A)Rs may explain their importance in stress-, ovarian cycle-, and pregnancy-related mood disorders. Moreover, disruptions in network dynamics associated with schizophrenia, epilepsy, and Parkinson's disease may well involve alterations in the tonic GABA(A)R-mediated conductance. Extrasynaptic GABA(A)Rs may therefore present a therapeutic target for treatment of these diseases, with the potential to enhance cognition and aid poststroke functional recovery.
在过去的二十年中,研究已经确定了位于突触外的 GABA(A) 受体群体,这些受体使神经元能够感知细胞外间隙中存在的低环境 GABA 浓度,从而产生一种以前在神经元兴奋性研究中未被考虑的紧张性抑制。这种紧张性抑制在调节意识状态中的重要性,突出表现在 extrasynaptic GABA(A) 受体 (GABA(A)Rs) 被认为是麻醉剂、促进睡眠的药物、神经甾体和酒精的关键靶标。这些突触外 GABA(A)Rs 的神经甾体敏感性可以解释它们在与应激、卵巢周期和妊娠相关的情绪障碍中的重要性。此外,与精神分裂症、癫痫和帕金森病相关的网络动态紊乱很可能涉及紧张性 GABA(A)R 介导的电导率的改变。因此,突触外 GABA(A)Rs 可能成为治疗这些疾病的治疗靶点,具有增强认知和帮助中风后功能恢复的潜力。